Palatin Technologies, Inc. (OTCMKTS:PTNT – Get Free Report) shares passed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $11.77 and traded as high as $25.94. Palatin Technologies shares last traded at $25.94, with a volume of 132 shares trading hands.
Palatin Technologies Trading Down 0.5%
The company has a market capitalization of $25.24 million, a P/E ratio of -16.74 and a beta of 0.75. The company has a 50 day moving average price of $21.84 and a 200 day moving average price of $11.77.
About Palatin Technologies
Palatin Technologies, Inc, a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing oral PL8177, a selective MC1r agonist peptide that is in Phase 2 clinical trial for the treatment of inflammatory bowel diseases. In addition, the company engages in the development of PL9643, a peptide melanocortin agonist active at multiple MCrs, including MC1r and MC5r for anti-inflammatory ocular indications, such as dry eye disease, which is in Phase 3 clinical trial; and melanocortin peptides for diabetic retinopathy.
Featured Articles
- Five stocks we like better than Palatin Technologies
- MDA Space Targets US Defense Market With $620M Acquisition
- Carnival’s Second Quarter: Is the Stock Still Complicated?
- Domino’s Stock Slides to 52-Week Low as Investors Digest CEO Change
- Microsoft Solves AI’s Biggest Bottleneck With Chevron Deal
Receive News & Ratings for Palatin Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Palatin Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
